Predictors and Outcomes of Ventilated Hospital-Acquired Pneumonia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects comprehensive clinical data from patients diagnosed with hospital-acquired pneumonia, with a focus on those requiring mechanical ventilation. Researchers record demographics, prior antibiotics, treatments for HAP, ICU/hospital stays, comorbidities, and severity scores such as CURB-65, CRB-65, SMART-COP, and SMRT-CO. Blood tests, cultures, imaging, and arterial blood gases are gathered at diagnosis to explore associations between patient characteristics, pathogen profiles, and outcomes. The goal is to identify predictors that relate to morbidity and mortality in ventilated HAP patients and to understand how treatment patterns influence prognosis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

All patients diagnosed with HAP in the chest department, Assiut University

Exclusion Criteria:

1. Post operative patients
2. Tracheostomized patients
3. Comatosed patient since admission
4. Suspected aspiration

Where it's running

• Assiut University Gospital
  Asyut, Asyut Governorate, Egypt Recruiting

Study contacts

• Study coordinator: Entsar Hsanen Mohamed, dr
• Email: entsar.hsanen@aun.edu.eg
• Phone: 01019968106

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pneumonia After Heart Surgery: Can AI Predict It?

  This study tests whether artificial intelligence can predict hospital-acquired pneumonia after heart surgery and whether pneumonia can indicate higher risk of future heart and lung problems.

  Recruiting Tomsk National Research Medical Center of the Russian Academy of Sciences · Tomsk · NCT07745491

• Using dexamethasone to treat severe hospital-acquired pneumonia in critically ill patients

  This study is testing if adding dexamethasone to standard treatment helps critically ill patients with severe hospital-acquired pneumonia feel better compared to those who only get standard treatment.

  Recruiting at 19 sites Phase 3 Nantes University Hospital · Amiens and 33 other locations · NCT06269900

• Using acyclovir to treat pneumonia in ventilated patients with herpes simplex virus

  This study is testing if giving acyclovir to ICU patients on ventilators who have pneumonia and herpes simplex virus can help them survive better than those who don't receive the medication.

  Recruiting at 28 sites Phase 3 Jena University Hospital · Freiburg im Breisgau, Baden-Wurttemberg and 27 other locations · NCT06134492

• Early treatment with targeted antibiotics for severe infections using rapid diagnostics

  This study is testing if giving targeted antibiotics right away, based on quick test results, can help hospitalized patients with severe infections caused by tough-to-treat bacteria feel better faster than standard care.

  Recruiting at 21 sites Phase 4 National University of Singapore · Vellore and 20 other locations · NCT05979545

• Learning about the safety and effectiveness of Zavicefta in Korea

  This study is trying to learn how safe and effective Zavicefta is for treating serious infections in both adults and kids in Korea after it has been released for use.

  Recruiting Pfizer · Seoul, Gangnam-gu · NCT05733104

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.